Home/Filings/4/0001867096-24-000170
4//SEC Filing

Hecht Beth 4

Accession 0001867096-24-000170

CIK 0001867096other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:07 PM ET

Size

17.0 KB

Accession

0001867096-24-000170

Insider Transaction Report

Form 4
Period: 2022-01-29
Hecht Beth
See Remarks
Transactions
  • Tax Payment

    Common Stock

    2023-01-03$1.12/sh33,488$37,5071,506,835 total
  • Tax Payment

    Common Stock

    2023-01-29$1.26/sh21,177$26,6831,485,658 total
  • Tax Payment

    Common Stock

    2023-01-31$1.24/sh5,784$7,1721,479,874 total
  • Tax Payment

    Common Stock

    2024-01-03$2.24/sh33,488$75,0131,446,386 total
  • Tax Payment

    Common Stock

    2024-01-29$2.66/sh19,675$52,3361,426,711 total
  • Tax Payment

    Common Stock

    2022-01-29$2.11/sh14,037$29,6181,544,771 total
  • Tax Payment

    Common Stock

    2022-01-31$2.11/sh4,448$9,3851,540,323 total
  • Tax Payment

    Common Stock

    2024-01-31$2.46/sh45,909$112,9361,380,802 total
Footnotes (10)
  • [F1]This transaction is being reported late due to administrative oversight.
  • [F10]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.
  • [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2022.
  • [F3]These shares include 3,840 shares that were purchased on June 30, 2024 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
  • [F4]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022.
  • [F5]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023.
  • [F6]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023.
  • [F7]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.
  • [F8]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.
  • [F9]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.

Issuer

Xeris Biopharma Holdings, Inc.

CIK 0001867096

Entity typeother

Related Parties

1
  • filerCIK 0001652410

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:07 PM ET
Size
17.0 KB